Browsing: ASTRUM005

Support

Real-World Serplulimab Combo Outcomes Validate ASTRUM-005 Trial in ES-SCLC

By NewsCancerJuly 23, 20260

First-line serplulimab (Hetronifly) plus chemotherapy yielded real-world survival outcomes consistent with the pivotal phase 3 ASTRUM-005 trial (NCT04063163) in patients…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Dover cancer survivor backs Breast Cancer Now’s campaign

Second-Line Treatment Strategies and Emerging Challenges

Establishing the Frontline Monotherapy Backbone in EGFR-Mutant NSCLC

Browsing: ASTRUM005

Real-World Serplulimab Combo Outcomes Validate ASTRUM-005 Trial in ES-SCLC

Dover cancer survivor backs Breast Cancer Now’s campaign

Second-Line Treatment Strategies and Emerging Challenges

Establishing the Frontline Monotherapy Backbone in EGFR-Mutant NSCLC

Real-World Serplulimab Combo Outcomes Validate ASTRUM-005 Trial in ES-SCLC

Dover cancer survivor backs Breast Cancer Now’s campaign

Second-Line Treatment Strategies and Emerging Challenges

Establishing the Frontline Monotherapy Backbone in EGFR-Mutant NSCLC

Real-World Serplulimab Combo Outcomes Validate ASTRUM-005 Trial in ES-SCLC

Latest Post

Dover cancer survivor backs Breast Cancer Now’s campaign

Second-Line Treatment Strategies and Emerging Challenges

Establishing the Frontline Monotherapy Backbone in EGFR-Mutant NSCLC

Subscribe to Updates

What's Hot

Browsing: ASTRUM005